行业迈向精准服务新阶段，圆心惠保凭特药服务创新再获权威认可

Core Insights - Round Heart Insurance was awarded the "Annual Outstanding Beneficial Insurance Special Drug Service Provider" at the 2025 Sina Finance Golden Unicorn Insurance Industry Awards, reflecting the deepening of China's multi-tiered medical security system and the continuous upgrade of beneficial insurance [1][6] Industry Developments - In recent years, to meet the urgent demand for high-priced cancer drugs and rare disease medications, the coverage responsibilities of beneficial insurance products across the country have been continuously upgraded, with special drug coverage becoming a core element of differentiation and "big disease" positioning [3][8] - The implementation of the first version of the "Commercial Health Insurance Innovative Drug Catalog" in December 2025 provides clear policy guidance and significant opportunities for commercial health insurance to support innovative drug payments [4][9] Company Initiatives - Round Heart Insurance has developed an intelligent service closed loop that connects medical, pharmaceutical, and insurance resources, enhancing the accessibility and affordability of high-priced special drugs, thereby translating the increasingly rich special drug coverage into tangible benefits for patients [4][9] - In 2025, Round Heart Insurance participated in the operation and service of 40 beneficial insurance projects nationwide and expanded coverage to special groups such as veterans, indicating the depth and breadth of its services are evolving in line with industry trends to meet diverse public welfare needs [4][9] Future Outlook - The beneficial insurance industry has entered a high-quality development stage focused on "precise pricing" and "value competition," shifting attention from expanding coverage to enhancing the effectiveness and sustainability of insurance through scientific design of special drug coverage, refined management of medication processes, and optimized claims and service experiences [4][9] - The award received by Round Heart Insurance symbolizes its commitment to deepening special drug services and enhancing the effectiveness of beneficial insurance, highlighting the need for more participants grounded in solid service and technological innovation to contribute positively to the social security safety net [5][10]